Global Traveler's Diarrhea Therapeutics Market Growth 2021-2026

Publisher Name :
Date: 28-Jun-2021
No. of pages: 92

According to this latest study, the 2021 growth of Traveler's Diarrhea Therapeutics will have significant change from previous year. By the most conservative estimates of global Traveler's Diarrhea Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 724.7 million in 2020. Over the next five years the Traveler's Diarrhea Therapeutics market will register a 7.4% CAGR in terms of revenue, the global market size will reach US$ 963 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Traveler's Diarrhea Therapeutics market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

- Immunization

- Non-antibiotic Agents

- Antibiotics

- Anti-Motility Agents

- Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

- Adult Traveler's Diarrhea

- Children Traveler's Diarrhea

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

- Salix Pharmaceuticals

- P&G

- Johnson & Johnson

- Otsuka Pharma

- Valneva

- Shanghai United Cell

- PaxVax

- Livzon

- Immuron

Global Traveler's Diarrhea Therapeutics Market Growth 2021-2026

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Traveler's Diarrhea Therapeutics Consumption 2016-2026
2.1.2 Traveler's Diarrhea Therapeutics Consumption CAGR by Region
2.2 Traveler's Diarrhea Therapeutics Segment by Type
2.2.1 Immunization
2.2.2 Non-antibiotic Agents
2.2.3 Antibiotics
2.2.4 Anti-Motility Agents
2.2.5 Others
2.3 Traveler's Diarrhea Therapeutics Sales by Type
2.3.1 Global Traveler's Diarrhea Therapeutics Sales Market Share by Type (2016-2021)
2.3.2 Global Traveler's Diarrhea Therapeutics Revenue and Market Share by Type (2016-2021)
2.3.3 Global Traveler's Diarrhea Therapeutics Sale Price by Type (2016-2021)
2.4 Traveler's Diarrhea Therapeutics Segment by Application
2.4.1 Adult Traveler's Diarrhea
2.4.2 Children Traveler's Diarrhea
2.5 Traveler's Diarrhea Therapeutics Sales by Application
2.5.1 Global Traveler's Diarrhea Therapeutics Sale Market Share by Application (2016-2021)
2.5.2 Global Traveler's Diarrhea Therapeutics Revenue and Market Share by Application (2016-2021)
2.5.3 Global Traveler's Diarrhea Therapeutics Sale Price by Application (2016-2021)

3 Global Traveler's Diarrhea Therapeutics by Company
3.1 Global Traveler's Diarrhea Therapeutics Sales Market Share by Company
3.1.1 Global Traveler's Diarrhea Therapeutics Sales by Company (2019-2021)
3.1.2 Global Traveler's Diarrhea Therapeutics Sales Market Share by Company (2019-2021)
3.2 Global Traveler's Diarrhea Therapeutics Revenue Market Share by Company
3.2.1 Global Traveler's Diarrhea Therapeutics Revenue by Company (2019-2021)
3.2.2 Global Traveler's Diarrhea Therapeutics Revenue Market Share by Company (2019-2021)
3.3 Global Traveler's Diarrhea Therapeutics Sale Price by Company
3.4 Global Manufacturers Traveler's Diarrhea Therapeutics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Traveler's Diarrhea Therapeutics Product Location Distribution
3.4.2 Players Traveler's Diarrhea Therapeutics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Traveler's Diarrhea Therapeutics by Region
4.1 Global Traveler's Diarrhea Therapeutics by Region
4.1.1 Global Traveler's Diarrhea Therapeutics Sales by Region
4.1.2 Global Traveler's Diarrhea Therapeutics Revenue by Region
4.2 Americas Traveler's Diarrhea Therapeutics Sales Growth
4.3 APAC Traveler's Diarrhea Therapeutics Sales Growth
4.4 Europe Traveler's Diarrhea Therapeutics Sales Growth
4.5 Middle East & Africa Traveler's Diarrhea Therapeutics Sales Growth

5 Americas
5.1 Americas Traveler's Diarrhea Therapeutics Sales by Country
5.1.1 Americas Traveler's Diarrhea Therapeutics Sales by Country (2016-2021)
5.1.2 Americas Traveler's Diarrhea Therapeutics Revenue by Country (2016-2021)
5.2 Americas Traveler's Diarrhea Therapeutics Sales by Type
5.3 Americas Traveler's Diarrhea Therapeutics Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Traveler's Diarrhea Therapeutics Sales by Region
6.1.1 APAC Traveler's Diarrhea Therapeutics Sales by Region (2016-2021)
6.1.2 APAC Traveler's Diarrhea Therapeutics Revenue by Region (2016-2021)
6.2 APAC Traveler's Diarrhea Therapeutics Sales by Type
6.3 APAC Traveler's Diarrhea Therapeutics Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Traveler's Diarrhea Therapeutics by Country
7.1.1 Europe Traveler's Diarrhea Therapeutics Sales by Country (2016-2021)
7.1.2 Europe Traveler's Diarrhea Therapeutics Revenue by Country (2016-2021)
7.2 Europe Traveler's Diarrhea Therapeutics Sales by Type
7.3 Europe Traveler's Diarrhea Therapeutics Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Traveler's Diarrhea Therapeutics by Country
8.1.1 Middle East & Africa Traveler's Diarrhea Therapeutics Sales by Country (2016-2021)
8.1.2 Middle East & Africa Traveler's Diarrhea Therapeutics Revenue by Country (2016-2021)
8.2 Middle East & Africa Traveler's Diarrhea Therapeutics Sales by Type
8.3 Middle East & Africa Traveler's Diarrhea Therapeutics Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Traveler's Diarrhea Therapeutics Distributors
10.3 Traveler's Diarrhea Therapeutics Customer

11 Global Traveler's Diarrhea Therapeutics Market Forecast
11.1 Global Traveler's Diarrhea Therapeutics Forecast by Region
11.1.1 Global Traveler's Diarrhea Therapeutics Forecast by Regions (2021-2026)
11.2.2 Global Traveler's Diarrhea Therapeutics Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Traveler's Diarrhea Therapeutics Forecast by Type
11.7 Global Traveler's Diarrhea Therapeutics Forecast by Application

12 Key Players Analysis
12.1 Salix Pharmaceuticals
12.1.1 Salix Pharmaceuticals Company Information
12.1.2 Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Product Offered
12.1.3 Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Salix Pharmaceuticals Main Business Overview
12.1.5 Salix Pharmaceuticals Latest Developments
12.2 P&G
12.2.1 P&G Company Information
12.2.2 P&G Traveler's Diarrhea Therapeutics Product Offered
12.2.3 P&G Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 P&G Main Business Overview
12.2.5 P&G Latest Developments
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Company Information
12.3.2 Johnson & Johnson Traveler's Diarrhea Therapeutics Product Offered
12.3.3 Johnson & Johnson Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Johnson & Johnson Main Business Overview
12.3.5 Johnson & Johnson Latest Developments
12.4 Otsuka Pharma
12.4.1 Otsuka Pharma Company Information
12.4.2 Otsuka Pharma Traveler's Diarrhea Therapeutics Product Offered
12.4.3 Otsuka Pharma Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Otsuka Pharma Main Business Overview
12.4.5 Otsuka Pharma Latest Developments
12.5 Valneva
12.5.1 Valneva Company Information
12.5.2 Valneva Traveler's Diarrhea Therapeutics Product Offered
12.5.3 Valneva Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Valneva Main Business Overview
12.5.5 Valneva Latest Developments
12.6 Shanghai United Cell
12.6.1 Shanghai United Cell Company Information
12.6.2 Shanghai United Cell Traveler's Diarrhea Therapeutics Product Offered
12.6.3 Shanghai United Cell Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Shanghai United Cell Main Business Overview
12.6.5 Shanghai United Cell Latest Developments
12.7 PaxVax
12.7.1 PaxVax Company Information
12.7.2 PaxVax Traveler's Diarrhea Therapeutics Product Offered
12.7.3 PaxVax Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 PaxVax Main Business Overview
12.7.5 PaxVax Latest Developments
12.8 Livzon
12.8.1 Livzon Company Information
12.8.2 Livzon Traveler's Diarrhea Therapeutics Product Offered
12.8.3 Livzon Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Livzon Main Business Overview
12.8.5 Livzon Latest Developments
12.9 Immuron
12.9.1 Immuron Company Information
12.9.2 Immuron Traveler's Diarrhea Therapeutics Product Offered
12.9.3 Immuron Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Immuron Main Business Overview
12.9.5 Immuron Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Traveler's Diarrhea Therapeutics Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Immunization
Table 3. Major Players of Non-antibiotic Agents
Table 4. Major Players of Antibiotics
Table 5. Major Players of Anti-Motility Agents
Table 6. Major Players of Others
Table 7. Global Traveler's Diarrhea Therapeutics Sales by Type (2016-2021) & (K Units)
Table 8. Global Traveler's Diarrhea Therapeutics Sales Market Share by Type (2016-2021)
Table 9. Global Traveler's Diarrhea Therapeutics Revenue by Type (2016-2021) & ($ million)
Table 10. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Type (2016-2021)
Table 11. Global Traveler's Diarrhea Therapeutics Sale Price by Type (2016-2021)
Table 12. Global Traveler's Diarrhea Therapeutics Sales by Application (2016-2021) & (K Units)
Table 13. Global Traveler's Diarrhea Therapeutics Sales Market Share by Application (2016-2021)
Table 14. Global Traveler's Diarrhea Therapeutics Value by Application (2016-2021)
Table 15. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Application (2016-2021)
Table 16. Global Traveler's Diarrhea Therapeutics Sale Price by Application (2016-2021)
Table 17. Global Traveler's Diarrhea Therapeutics Sales by Company (2019-2021) & (K Units)
Table 18. Global Traveler's Diarrhea Therapeutics Sales Market Share by Company (2019-2021)
Table 19. Global Traveler's Diarrhea Therapeutics Revenue by Company (2019-2021) ($ Millions)
Table 20. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Company (2019-2021)
Table 21. Global Traveler's Diarrhea Therapeutics Sale Price by Company (2019-2021)
Table 22. Key Manufacturers Traveler's Diarrhea Therapeutics Producing Area Distribution and Sales Area
Table 23. Players Traveler's Diarrhea Therapeutics Products Offered
Table 24. Traveler's Diarrhea Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Traveler's Diarrhea Therapeutics Sales by Region (2016-2021) (K Units)
Table 28. Global Traveler's Diarrhea Therapeutics Sales Market Share by Region (2016-2021)
Table 29. Global Traveler's Diarrhea Therapeutics Revenue by Region (2016-2021) & ($ Millions)
Table 30. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Region (2016-2021)
Table 31. Americas Traveler's Diarrhea Therapeutics Sales by Country (2016-2021) & (K Units)
Table 32. Americas Traveler's Diarrhea Therapeutics Sales Market Share by Country (2016-2021)
Table 33. Americas Traveler's Diarrhea Therapeutics Revenue by Country (2016-2021) & ($ Millions)
Table 34. Americas Traveler's Diarrhea Therapeutics Revenue Market Share by Country (2016-2021)
Table 35. Americas Traveler's Diarrhea Therapeutics Sales by Type (2016-2021) & (K Units)
Table 36. Americas Traveler's Diarrhea Therapeutics Sales Market Share by Type (2016-2021)
Table 37. Americas Traveler's Diarrhea Therapeutics Sales by Application (2016-2021) & (K Units)
Table 38. Americas Traveler's Diarrhea Therapeutics Sales Market Share by Application (2016-2021)
Table 39. APAC Traveler's Diarrhea Therapeutics Sales by Region (2016-2021) & (K Units)
Table 40. APAC Traveler's Diarrhea Therapeutics Sales Market Share by Region (2016-2021)
Table 41. APAC Traveler's Diarrhea Therapeutics Revenue by Region (2016-2021) & ($ Millions)
Table 42. APAC Traveler's Diarrhea Therapeutics Revenue Market Share by Region (2016-2021)
Table 43. APAC Traveler's Diarrhea Therapeutics Sales by Type (2016-2021) & (K Units)
Table 44. APAC Traveler's Diarrhea Therapeutics Sales Market Share by Type (2016-2021)
Table 45. APAC Traveler's Diarrhea Therapeutics Sales by Application (2016-2021) & (K Units)
Table 46. APAC Traveler's Diarrhea Therapeutics Sales Market Share by Application (2016-2021)
Table 47. Europe Traveler's Diarrhea Therapeutics Sales by Country (2016-2021) & (K Units)
Table 48. Europe Traveler's Diarrhea Therapeutics Sales Market Share by Country (2016-2021)
Table 49. Europe Traveler's Diarrhea Therapeutics Revenue by Country (2016-2021) & ($ Millions)
Table 50. Europe Traveler's Diarrhea Therapeutics Revenue Market Share by Country (2016-2021)
Table 51. Europe Traveler's Diarrhea Therapeutics Sales by Type (2016-2021) & (K Units)
Table 52. Europe Traveler's Diarrhea Therapeutics Sales Market Share by Type (2016-2021)
Table 53. Europe Traveler's Diarrhea Therapeutics Sales by Application (2016-2021) & (K Units)
Table 54. Europe Traveler's Diarrhea Therapeutics Sales Market Share by Application (2016-2021)
Table 55. Middle East & Africa Traveler's Diarrhea Therapeutics Sales by Country (2016-2021) & (K Units)
Table 56. Middle East & Africa Traveler's Diarrhea Therapeutics Sales Market Share by Country (2016-2021)
Table 57. Middle East & Africa Traveler's Diarrhea Therapeutics Revenue by Country (2016-2021) & ($ Millions)
Table 58. Middle East & Africa Traveler's Diarrhea Therapeutics Revenue Market Share by Country (2016-2021)
Table 59. Middle East & Africa Traveler's Diarrhea Therapeutics Sales by Type (2016-2021) & (K Units)
Table 60. Middle East & Africa Traveler's Diarrhea Therapeutics Sales Market Share by Type (2016-2021)
Table 61. Middle East & Africa Traveler's Diarrhea Therapeutics Sales by Application (2016-2021) & (K Units)
Table 62. Middle East & Africa Traveler's Diarrhea Therapeutics Sales Market Share by Application (2016-2021)
Table 63. Key and Potential Regions of Traveler's Diarrhea Therapeutics
Table 64. Key Application and Potential Industries of Traveler's Diarrhea Therapeutics
Table 65. Key Challenges of Traveler's Diarrhea Therapeutics
Table 66. Key Trends of Traveler's Diarrhea Therapeutics
Table 67. Traveler's Diarrhea Therapeutics Distributors List
Table 68. Traveler's Diarrhea Therapeutics Customer List
Table 69. Global Traveler's Diarrhea Therapeutics Sales Forecast by Region (2021-2026) & (K Units)
Table 70. Global Traveler's Diarrhea Therapeutics Consumption Market Forecast by Region
Table 71. Global Traveler's Diarrhea Therapeutics Revenue Forecast by Region (2021-2026) & ($ millions)
Table 72. Global Traveler's Diarrhea Therapeutics Revenue Market Share Forecast by Region (2021-2026)
Table 73. Americas Traveler's Diarrhea Therapeutics Sales Forecast by Country (2021-2026) & (K Units)
Table 74. Americas Traveler's Diarrhea Therapeutics Revenue Forecast by Country (2021-2026) & ($ millions)
Table 75. APAC Traveler's Diarrhea Therapeutics Sales Forecast by Region (2021-2026) & (K Units)
Table 76. APAC Traveler's Diarrhea Therapeutics Revenue Forecast by Region (2021-2026) & ($ millions)
Table 77. Europe Traveler's Diarrhea Therapeutics Sales Forecast by Country (2021-2026) & (K Units)
Table 78. Europe Traveler's Diarrhea Therapeutics Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Middle East & Africa Traveler's Diarrhea Therapeutics Sales Forecast by Country (2021-2026) & (K Units)
Table 80. Middle East & Africa Traveler's Diarrhea Therapeutics Revenue Forecast by Country (2021-2026) & ($ millions)
Table 81. Global Traveler's Diarrhea Therapeutics Sales Forecast by Type (2021-2026) & (K Units)
Table 82. Global Traveler's Diarrhea Therapeutics Sales Market Share Forecast by Type (2021-2026)
Table 83. Global Traveler's Diarrhea Therapeutics Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 84. Global Traveler's Diarrhea Therapeutics Revenue Market Share Forecast by Type (2021-2026)
Table 85. Global Traveler's Diarrhea Therapeutics Sales Forecast by Application (2021-2026) & (K Units)
Table 86. Global Traveler's Diarrhea Therapeutics Sales Market Share Forecast by Application (2021-2026)
Table 87. Global Traveler's Diarrhea Therapeutics Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 88. Global Traveler's Diarrhea Therapeutics Revenue Market Share Forecast by Application (2021-2026)
Table 89. Salix Pharmaceuticals Basic Information, Traveler's Diarrhea Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 90. Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Product Offered
Table 91. Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 92. Salix Pharmaceuticals Main Business
Table 93. Salix Pharmaceuticals Latest Developments
Table 94. P&G Basic Information, Traveler's Diarrhea Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 95. P&G Traveler's Diarrhea Therapeutics Product Offered
Table 96. P&G Traveler's Diarrhea Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 97. P&G Main Business
Table 98. P&G Latest Developments
Table 99. Johnson & Johnson Basic Information, Traveler's Diarrhea Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 100. Johnson & Johnson Traveler's Diarrhea Therapeutics Product Offered
Table 101. Johnson & Johnson Traveler's Diarrhea Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 102. Johnson & Johnson Main Business
Table 103. Johnson & Johnson Latest Developments
Table 104. Otsuka Pharma Basic Information, Traveler's Diarrhea Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 105. Otsuka Pharma Traveler's Diarrhea Therapeutics Product Offered
Table 106. Otsuka Pharma Traveler's Diarrhea Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 107. Otsuka Pharma Main Business
Table 108. Otsuka Pharma Latest Developments
Table 109. Valneva Basic Information, Traveler's Diarrhea Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 110. Valneva Traveler's Diarrhea Therapeutics Product Offered
Table 111. Valneva Traveler's Diarrhea Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 112. Valneva Main Business
Table 113. Valneva Latest Developments
Table 114. Shanghai United Cell Basic Information, Traveler's Diarrhea Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 115. Shanghai United Cell Traveler's Diarrhea Therapeutics Product Offered
Table 116. Shanghai United Cell Traveler's Diarrhea Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 117. Shanghai United Cell Main Business
Table 118. Shanghai United Cell Latest Developments
Table 119. PaxVax Basic Information, Traveler's Diarrhea Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 120. PaxVax Traveler's Diarrhea Therapeutics Product Offered
Table 121. PaxVax Traveler's Diarrhea Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 122. PaxVax Main Business
Table 123. PaxVax Latest Developments
Table 124. Livzon Basic Information, Traveler's Diarrhea Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 125. Livzon Traveler's Diarrhea Therapeutics Product Offered
Table 126. Livzon Traveler's Diarrhea Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 127. Livzon Main Business
Table 128. Livzon Latest Developments
Table 129. Immuron Basic Information, Traveler's Diarrhea Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 130. Immuron Traveler's Diarrhea Therapeutics Product Offered
Table 131. Immuron Traveler's Diarrhea Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 132. Immuron Main Business
Table 133. Immuron Latest Developments
List of Figures
Figure 1. Picture of Traveler's Diarrhea Therapeutics
Figure 2. Traveler's Diarrhea Therapeutics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Traveler's Diarrhea Therapeutics Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Traveler's Diarrhea Therapeutics Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Traveler's Diarrhea Therapeutics Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Immunization
Figure 10. Product Picture of Non-antibiotic Agents
Figure 11. Product Picture of Antibiotics
Figure 12. Product Picture of Anti-Motility Agents
Figure 13. Product Picture of Others
Figure 14. Global Traveler's Diarrhea Therapeutics Sales Market Share by Type in 2020
Figure 15. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Type (2016-2021)
Figure 16. Traveler's Diarrhea Therapeutics Consumed in Adult Traveler's Diarrhea
Figure 17. Global Traveler's Diarrhea Therapeutics Market: Adult Traveler's Diarrhea (2016-2021) & (K Units)
Figure 18. Traveler's Diarrhea Therapeutics Consumed in Children Traveler's Diarrhea
Figure 19. Global Traveler's Diarrhea Therapeutics Market: Children Traveler's Diarrhea (2016-2021) & (K Units)
Figure 20. Global Traveler's Diarrhea Therapeutics Sales Market Share by Application (2016-2021)
Figure 21. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Application in 2020
Figure 22. Traveler's Diarrhea Therapeutics Revenue Market by Company in 2020 ($ Million)
Figure 23. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Company in 2020
Figure 24. Global Traveler's Diarrhea Therapeutics Sales Market Share by Regions (2016-2021)
Figure 25. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Region in 2020
Figure 26. Americas Traveler's Diarrhea Therapeutics Sales 2016-2021 (K Units)
Figure 27. Americas Traveler's Diarrhea Therapeutics Revenue 2016-2021 ($ Millions)
Figure 28. APAC Traveler's Diarrhea Therapeutics Sales 2016-2021 (K Units)
Figure 29. APAC Traveler's Diarrhea Therapeutics Revenue 2016-2021 ($ Millions)
Figure 30. Europe Traveler's Diarrhea Therapeutics Sales 2016-2021 (K Units)
Figure 31. Europe Traveler's Diarrhea Therapeutics Revenue 2016-2021 ($ Millions)
Figure 32. Middle East & Africa Traveler's Diarrhea Therapeutics Sales 2016-2021 (K Units)
Figure 33. Middle East & Africa Traveler's Diarrhea Therapeutics Revenue 2016-2021 ($ Millions)
Figure 34. Americas Traveler's Diarrhea Therapeutics Sales Market Share by Country in 2020
Figure 35. Americas Traveler's Diarrhea Therapeutics Revenue Market Share by Country in 2020
Figure 36. Americas Traveler's Diarrhea Therapeutics Sales Market Share by Type in 2020
Figure 37. Americas Traveler's Diarrhea Therapeutics Sales Market Share by Application in 2020
Figure 38. United States Traveler's Diarrhea Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 39. Canada Traveler's Diarrhea Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 40. Mexico Traveler's Diarrhea Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 41. Brazil Traveler's Diarrhea Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 42. APAC Traveler's Diarrhea Therapeutics Sales Market Share by Region in 2020
Figure 43. APAC Traveler's Diarrhea Therapeutics Revenue Market Share by Regions in 2020
Figure 44. APAC Traveler's Diarrhea Therapeutics Sales Market Share by Type in 2020
Figure 45. APAC Traveler's Diarrhea Therapeutics Sales Market Share by Application in 2020
Figure 46. China Traveler's Diarrhea Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 47. Japan Traveler's Diarrhea Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 48. Korea Traveler's Diarrhea Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 49. Southeast Asia Traveler's Diarrhea Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 50. India Traveler's Diarrhea Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 51. Australia Traveler's Diarrhea Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 52. Europe Traveler's Diarrhea Therapeutics Sales Market Share by Country in 2020
Figure 53. Europe Traveler's Diarrhea Therapeutics Revenue Market Share by Country in 2020
Figure 54. Europe Traveler's Diarrhea Therapeutics Sales Market Share by Type in 2020
Figure 55. Europe Traveler's Diarrhea Therapeutics Sales Market Share by Application in 2020
Figure 56. Germany Traveler's Diarrhea Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 57. France Traveler's Diarrhea Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 58. UK Traveler's Diarrhea Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 59. Italy Traveler's Diarrhea Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 60. Russia Traveler's Diarrhea Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 61. Middle East & Africa Traveler's Diarrhea Therapeutics Sales Market Share by Country in 2020
Figure 62. Middle East & Africa Traveler's Diarrhea Therapeutics Revenue Market Share by Country in 2020
Figure 63. Middle East & Africa Traveler's Diarrhea Therapeutics Sales Market Share by Type in 2020
Figure 64. Middle East & Africa Traveler's Diarrhea Therapeutics Sales Market Share by Application in 2020
Figure 65. Egypt Traveler's Diarrhea Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 66. South Africa Traveler's Diarrhea Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 67. Israel Traveler's Diarrhea Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 68. Turkey Traveler's Diarrhea Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 69. GCC Country Traveler's Diarrhea Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs